Your browser doesn't support javascript.
loading
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
O'Neil, B H; Scott, A J; Ma, W W; Cohen, S J; Aisner, D L; Menter, A R; Tejani, M A; Cho, J K; Granfortuna, J; Coveler, L; Olowokure, O O; Baranda, J C; Cusnir, M; Phillip, P; Boles, J; Nazemzadeh, R; Rarick, M; Cohen, D J; Radford, J; Fehrenbacher, L; Bajaj, R; Bathini, V; Fanta, P; Berlin, J; McRee, A J; Maguire, R; Wilhelm, F; Maniar, M; Jimeno, A; Gomes, C L; Messersmith, W A.
Afiliación
  • O'Neil BH; Simon Cancer Center, Indiana University School of Medicine, Indianapolis.
  • Scott AJ; University of Colorado, Denver, Aurora.
  • Ma WW; Roswell Park Cancer Institute, Buffalo.
  • Cohen SJ; Fox Chase Cancer Center, Philadelphia.
  • Aisner DL; University of Colorado, Denver, Aurora.
  • Menter AR; Kaiser Permanente, Lone Tree.
  • Tejani MA; University of Rochester Medical Center, Rochester.
  • Cho JK; Oncare Hawaii, Honolulu.
  • Granfortuna J; Cone Health Cancer Center, Greensboro.
  • Coveler L; University of Washington, Seattle.
  • Olowokure OO; University of Cincinnati Cancer Institute, Cincinnati.
  • Baranda JC; University of Kansas Medical Center, Westwood.
  • Cusnir M; Mount Sinai Medical Center, Miami Beach.
  • Phillip P; Karmanos Cancer Institute, Detroit.
  • Boles J; Rex Cancer Center UNC Healthcare, Raleigh.
  • Nazemzadeh R; Carolinas Health Care, Charlotte.
  • Rarick M; Kaiser Permanante Northwest, Portland.
  • Cohen DJ; NYU Clinical Cancer Center, New York.
  • Radford J; Hendersonville Hematology and Oncology at Pardee, Hendersonville.
  • Fehrenbacher L; Kaiser Permanante Medical Center, Vallejo.
  • Bajaj R; McLeod Regional Medical Center, Florence.
  • Bathini V; University of Massachusetts Memorial, Worcester.
  • Fanta P; UCSD Moores Cancer Center, La Jolla.
  • Berlin J; Vanderbilt-Ingram Cancer Center, Nashville.
  • McRee AJ; UNC Lineberger Comprehensive Cancer Center, Chapel Hill.
  • Maguire R; Onconova Therapeutics Inc., Newtown.
  • Wilhelm F; Onconova Therapeutics Inc., Newtown.
  • Maniar M; Onconova Therapeutics Inc., Newtown.
  • Jimeno A; University of Colorado, Denver, Aurora.
  • Gomes CL; Oncology Consortia of Criterium Inc., Saratoga Springs, USA.
  • Messersmith WA; University of Colorado, Denver, Aurora. Electronic address: wells.messersmith@ucdenver.edu.
Ann Oncol ; 26(9): 1923-1929, 2015 09.
Article en En | MEDLINE | ID: mdl-26091808
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Sulfonas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina / Glicina Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Sulfonas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina / Glicina Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article